Minneapolis, MN, United States of America

Edward H Lambert

This inventor holds 1 USPTO granted patent. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 1993.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Edward H Lambert: Innovator in Immunoassay Technology

Introduction

Edward H Lambert is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of small cell lung carcinoma. His innovative work has the potential to improve early diagnosis and treatment options for patients suffering from this aggressive form of cancer.

Latest Patents

Edward H Lambert holds a patent for an immunoassay specifically designed for small cell lung carcinoma. This patent, titled "Immunoassay for small cell lung carcinoma," utilizes small cell lung carcinoma voltage-gated calcium channel antigen (SCC-VGCC Ag) along with a detectable label and antibodies against SCC-VGCC Ag to effectively detect endogenous SCC-VGCC Ag. This advancement represents a crucial step in enhancing diagnostic accuracy for this type of cancer.

Career Highlights

Edward H Lambert is affiliated with the Mayo Foundation for Medical Education and Research, a prestigious institution known for its commitment to medical research and education. His work at Mayo has allowed him to collaborate with leading experts in the field, furthering the impact of his innovations.

Collaborations

Some of his notable coworkers include Thomas J Kryzer and Vanda A Lennon. Their collaborative efforts contribute to the advancement of research and development in medical diagnostics.

Conclusion

Edward H Lambert's contributions to immunoassay technology exemplify the importance of innovation in the medical field. His work not only enhances diagnostic capabilities but also paves the way for improved patient outcomes in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…